Controversy Over Trump’s Research Funding Rule

The Trump administration faces significant resistance to a proposed rule affecting scientific grant funding. Critics include patient groups, scientists, lawmakers from both parties, and pharmaceutical companies. They argue this move could politicize funding decisions and harm America’s leadership in biomedical research.

The proposed rule from the White House Office of Management and Budget (OMB) has attracted nearly 342,000 comments, mostly opposing the changes. The deadline for comments was Monday, and the agency plans to finalize the rule by October 1.

This rule seeks to formalize policies initially attempted through executive order and at agency levels. It would require senior administration officials to review all federal discretionary awards. They could deny grants based on alignment with the president’s agenda, and existing awards could be revoked without warning.

Additionally, the rule would ban grant conditions for research on diversity, equity, inclusion, and gender. It would also broadly restrict international scientific collaborations, even as China’s rapid advancements pose a threat to U.S. research supremacy.

The White House argues this rule is needed to enhance transparency and reduce government waste, fraud, and abuse. However, on Monday, 57 leading patient advocacy groups urged Congress to push for the withdrawal of the rule. Representing millions with chronic and acute illnesses, these organizations warn it could erode the U.S. role as a global science leader and disrupt clinical trials.

Background and Implications

The Department of Health and Human Services (HHS) inspector general reported $5.56 billion in expected recoveries over six months. This includes barring over 1,200 individuals and companies from federal programs.

The sudden passing of Sen. Lindsey Graham at 71 due to an aortic dissection highlights a rare, often fatal condition. Meanwhile, a second U.S. citizen was diagnosed with Ebola and transferred to Germany for treatment.

The Senate HELP Committee plans to hold confirmation hearings for the CDC director and HHS Assistant Secretary for Preparedness and Response.

Multiple states are suing the Department of Education over what they claim is an illegal end to mental health grants for public school students.

Additional Developments

California Governor Gavin Newsom supports Medicaid funding for housing and food despite GOP fraud claims. In Virginia, eight school-based health clinics closed due to federal funding pressures.

Notably, Missouri’s governor signed a bipartisan healthcare law. Other states face Medicaid cuts, affecting family caregivers financially.